XinVivo, Inc.赞助的临床试验
总计35837个结果
-
InVivo Therapeutics终止
-
University of North Carolina, Chapel HillNorth Carolina Translational and Clinical Sciences Institute; XinVivo, Inc.完全的
-
Xinqiao Hospital of Chongqing终止
-
Xinqiao Hospital of Chongqing完全的
-
Xinqiao Hospital of ChongqingChongqing Medical University尚未招聘沙利度胺增强西妥昔单抗联合标准化疗治疗左结直肠癌的临床疗效